Calumet (CLMT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 May, 2026Executive summary
Q1 2026 Adjusted EBITDA with Tax Attributes was $50.1 million, down from $55 million in Q1 2025, impacted by Shreveport production loss but offset by strong margin environments, specialty price increases, and record TruFuel sales.
Montana Renewables completed turnaround and MaxSAF 150 expansion, resuming full operations in May and positioning for increased SAF production.
EPA's SET2 RVO announcement in March 2026 reset the biofuels industry outlook, supporting strong, stable margins and incentivizing utilization growth.
Shreveport plant resumed normal operations in April after downtime caused by crude contamination.
Entered into a Second Omnibus Amendment Agreement with J. Aron & Company LLC, extending and amending key inventory monetization, supply, and financing agreements for the Shreveport refinery through January 31, 2030.
Financial highlights
Q1 2026 net loss widened to $317.0 million from $162.0 million year-over-year, primarily due to non-cash RINs and mark-to-market items.
Adjusted EBITDA with Tax Attributes was $50.1 million, down from $55 million in Q1 2025.
Specialty Products and Solutions Adjusted EBITDA: $44.3 million (Q1 2026) vs $56.3 million (Q1 2025); margin $54.00/bbl vs $57.01/bbl.
Performance Brands Adjusted EBITDA: $12.6 million (Q1 2026) vs $15.8 million (Q1 2025); record TruFuel sales.
Montana Renewables Adjusted EBITDA with Tax Attributes: $10.2 million (Q1 2026) vs $3.3 million (Q1 2025); index margin rose from $0.59/gal to $3.15/gal.
Outlook and guidance
Fuels and specialty markets are well positioned for the remainder of 2026, with strong margin environment and continued specialty price increases.
Renewables business at a positive inflection point, with a 4-5x increase in SAF volumes anticipated on an annual run rate basis.
SET2 RVO finalized in March 2026 supports robust renewable diesel and SAF demand.
No change in the plan to eventually monetize Montana Renewables; focus remains on demonstrating earnings power post-expansion.
Positioned to accelerate deleveraging and pursue long-term growth as operational improvements take effect.
Latest events from Calumet
- Board refreshed, financials strong, and all proposals approved as growth initiatives advance.CLMT
AGM 20262 Jun 2026 - 2025 saw strong revenue, debt reduction, and major renewables growth; board urges support for all proposals.CLMT
Proxy filing18 May 2026 - Strong 2024 results, C-Corp conversion, and major SAF expansion drive governance and compensation focus.CLMT
Proxy filing18 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Q3 2025 net income surged to $313.4M, with record EBITDA and SAF expansion progress.CLMT
Q3 202518 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Adjusted EBITDA up 30% to $293.3M, $222M debt cut, and record specialty output achieved.CLMT
Q4 20257 Apr 2026 - Expanding SAF production and strong cash flow drive growth, supported by regulatory tailwinds.CLMT
H.C. Wainwright Renewables Fuels Virtual Day presentation25 Mar 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026